Cargando…

Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma

BACKGROUND: Soft tissue sarcoma (STS) is a class of malignant tumors originating from mesenchymal stroma with a poor prognosis. Accumulating evidence has proved that angiogenesis is an essential hallmark of tumors. Nevertheless, there is a paucity of comprehensive research exploring the association...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Binfeng, Li, Chenbei, Feng, Chengyao, Wang, Hua, Zhang, Haixia, Tu, Chao, He, Shasha, Li, Zhihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291125/ https://www.ncbi.nlm.nih.gov/pubmed/37377953 http://dx.doi.org/10.3389/fimmu.2023.1178436

Ejemplares similares

Integrative analysis of TROAP with molecular features, carcinogenesis, and related immune and pharmacogenomic characteristics in soft tissue sarcoma
por: Tu, Chao, et al.
Publicado: (2023)

Integration analysis based on fatty acid metabolism robustly predicts prognosis, dissecting immunity microenvironment and aiding immunotherapy for soft tissue sarcoma
por: Liu, Binfeng, et al.
Publicado: (2023)

Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma
por: Liu, Zhongyue, et al.
Publicado: (2022)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas
por: Qi, Lin, et al.
Publicado: (2022)

A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas
por: Liu, Binfeng, et al.
Publicado: (2022)

Integrated Analysis of TME and Hypoxia Identifies a Classifier to Predict Prognosis and Therapeutic Biomarkers in Soft Tissue Sarcomas
por: Xu, Ruiling, et al.
Publicado: (2022)

Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma
por: Qi, Lin, et al.
Publicado: (2022)

A bibliometric and visualization analysis of glucocorticoid-induced osteoporosis research from 2012 to 2021
por: Jiang, Buchan, et al.
Publicado: (2022)

m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma
por: Huang, Zhen-Dong, et al.
Publicado: (2021)

Prognostic significance of WT1 expression in soft tissue sarcoma
por: Kim, Ahrong, et al.
Publicado: (2014)

Expression of hypoxic markers and their prognostic significance in soft tissue sarcoma
por: KIM, JEUNG IL, et al.
Publicado: (2015)

Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: comments on a meta-analysis by Liang et al
por: Tu, Chao, et al.
Publicado: (2016)

Prognostic significance of histological invasion in high grade soft tissue sarcomas
por: Tsukushi, Satoshi, et al.
Publicado: (2014)

The regulatory role and therapeutic application of pyroptosis in musculoskeletal diseases
por: Wang, Siyu, et al.
Publicado: (2022)

Prognostic significance of CD155 mRNA expression in soft tissue sarcomas
por: ATSUMI, SATORU, et al.
Publicado: (2013)

Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas
por: Brahmi, M., et al.
Publicado: (2021)

Immunological and prognostic significance of novel ferroptosis-related genes in soft tissue sarcoma
por: Zhao, Jiazheng, et al.
Publicado: (2022)

A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity
por: Liu, Binfeng, et al.
Publicado: (2022)

The emerging applications and advancements of Raman spectroscopy in pediatric cancers
por: Li, Chenbei, et al.
Publicado: (2023)

The Role of a Multidisciplinary Team in the Diagnosis and Treatment of Bone and Soft Tissue Sarcomas: A Single-Center Experience
por: Pang, Ke, et al.
Publicado: (2022)

The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy
por: Wang, Hua, et al.
Publicado: (2022)

Intratumoral NKp46(+) natural killer cells are spatially distanced from T and MHC-I(+) cells with prognostic implications in soft tissue sarcoma
por: Cruz, Sylvia M., et al.
Publicado: (2023)

Prognostic factors for survival in soft tissue sarcoma.
por: el-Jabbour, J. N., et al.
Publicado: (1990)

Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas
por: Sorbye, Sveinung W., et al.
Publicado: (2011)

Significance of Circulating Tumor Cells in Soft Tissue Sarcoma
por: Nicolazzo, Chiara, et al.
Publicado: (2015)

Stemness Subtypes and Scoring System Predict Prognosis and Efficacy of Immunotherapy in Soft Tissue Sarcoma
por: Gu, Hui-Yun, et al.
Publicado: (2022)

Integrated Analysis of Nine Prognostic RNA-Binding Proteins in Soft Tissue Sarcoma
por: Lin, Lu-Lu, et al.
Publicado: (2021)

Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy
por: Rupp, Luise, et al.
Publicado: (2023)

m6A-related metabolism molecular classification with distinct prognosis and immunotherapy response in soft tissue sarcoma
por: Huang, Zhen-Dong, et al.
Publicado: (2022)

Biological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio in soft tissue sarcoma
por: Chan, Jason Yongsheng, et al.
Publicado: (2018)

The clinical prognostic significance of ezrin in patients with bone and soft tissue sarcomas: a meta‐analysis
por: Wang, Feng, et al.
Publicado: (2019)

Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma
por: Qi, Lin, et al.
Publicado: (2021)

Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review
por: Roulleaux Dugage, Matthieu, et al.
Publicado: (2021)

Epidemiology, pathological characteristics and survival of retroperitoneal soft‑tissue sarcomas compared with non‑retroperitoneal soft tissue sarcomas
por: Buja, Alessandra, et al.
Publicado: (2023)

Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
por: Smeland, Eivind, et al.
Publicado: (2012)

Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
por: Merry, Eve, et al.
Publicado: (2021)

Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas
por: Yang, Xia, et al.
Publicado: (2019)

Prognostic Significance of Thrombomodulin mRNA in High‐Grade Soft Tissue Sarcomas after 10 years
por: Asanuma, Kunihiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q0pjhfsk9ei9p05r9jing3r3eq